Sep 17, 2021

Featuring perspectives from Dr Krishnansu S Tewari and Ms Courtney Arn, including the following topics:

• Role of PARP Inhibitors in the Management of Ovarian Cancer
  • Introduction (0:00)
  • Case: A woman in her early 50s with Stage IIIC ovarian cancer and a germline BRCA1 mutation — Courtney Arn, CNP (15:09)
  • Case: A woman...

Sep 9, 2021

Featuring slide presentations and related discussion from Drs Mansoor Raza Mirza, David O'Malley and Angeles Alvarez Secord, including the following topics:

• Contemporary Biomarker Assessment in Advanced Endometrial Cancer and Cervical Cancer — Mansoor Raza Mirza, MD (0:00)
• Current Treatment Planning for Patients with...

Sep 9, 2021

Featuring perspectives from Drs Mansoor Raza Mirza, David O'Malley and Angeles Alvarez Secord, including the following topics:

• Introduction (0:00)
• Current Treatment Planning for Patients with Advanced Endometrial Cancer (10:27)
• Selection of Therapy for Patients with Advanced Cervical Cancer (36:39)

CME information and...

Sep 2, 2021

Featuring an interview with Dr Kathleen Moore, including the following topics:

• Optimal treatment duration of bevacizumab in combination with paclitaxel/carboplatin for advanced ovarian cancer (0:00)
• Phase III PAOLA-1 trial subgroup analysis: Progression-free survival outcomes by disease stage in patients with...

Aug 12, 2021

Featuring slide presentations and related discussion from Drs Michael J Birrer, Kathleen Moore and Richard T Penson, including the following topics:

Genetic Testing in Ovarian Cancer; Integration of PARP Inhibitor Maintenance into the Management of Newly Diagnosed Disease — Michael J Birrer, MD, PhD (0:00)

Selection...